Regencell Bioscience Holdings annual total debt
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Total Debt Growth & History (RGC)
Regencell Bioscience Holdings's total debt was $544,415 for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $544,415 | $458,674 | +534.95% |
| 2024 | 2024-06-30 | $85,741 | −$377,928 | −81.51% |
| 2023 | 2023-06-30 | $463,669 | −$307,586 | −39.88% |
| 2022 | 2022-06-30 | $771,255 | −$2.5M | −76.27% |
| 2021 | 2021-06-30 | $3.3M | — | — |
Regencell Bioscience Holdings quarterly total debt
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-06-30 | $544,415 | $458,674 | +534.95% |
| Q4 2024 | 2024-06-30 | $85,741 | −$377,928 | −81.51% |
| Q4 2023 | 2023-06-30 | $463,669 | −$307,586 | −39.88% |
| Q4 2022 | 2022-06-30 | $771,255 | −$2.5M | −76.27% |
| Q4 2021 | 2021-06-30 | $3.3M | — | — |
Regencell Bioscience Holdings total debt trends
Between the periods ended 2021-06-30 and 2025-06-30, Regencell Bioscience Holdings's total debt decreased from $3.3M to $544,415, a change of −$2.7M. The latest reported quarter, Q4 2025, shows $544,415.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗